Table 4.
Detected gene(s) | ESBL/AmpC producer statusa | No. of E. coli isolates | % E. coli isolates (n = 359) |
---|---|---|---|
CMY | + | 78 | 21.73 |
SHV-12 | + | 47 | 13.12 |
CTX-M | + | 38 | 10.59 |
TEM-52 | + | 26 | 7.24 |
TEM-1 | (−) | 45 | 12.54 |
CMYand TEM-1 | + | 69 | 19.22 |
SHV-12 and TEM-1 | + | 33 | 9.12 |
CTX-M and CMY | + | 6 | 1.67 |
CTX-M and TEM-1 | + | 4 | 1.11 |
TEM-52 and SHV-12 | + | 2 | 0.56 |
TEM-52 and CMY | + | 1 | 0.28 |
SHV-12 and CTX-M | + | 1 | 0.28 |
CTX-M, SHV-12, and TEM-1 | + | 1 | 0.28 |
SHV-12, CMY, and TEM-1 | + | 1 | 0.28 |
Nonec | (−) | 7 | 1.95 |
Proven ESBL/AmpC producer | 307 | 85.51 |
+, proven to be an ESBL/AmpC producer; (−), still suspected of being an ESBL/AmpC producer.
Three hundred fifty-nine E. coli isolates suspected of being ESBL/AmpC producers were examined.
Negative in all PCRs.